Abstract:
Seventeen novel derivatives of hinokitiol, a monoterpene with a troponoide skeleton, were designed and synthesized. Their structures were confirmed by NMR and HRMS. The
in vitro bioassay results showed that the target compounds displayed satisfactory antifungal activities against
Rhizoctonia solani,
Botrytis cinerea,
Sclerotinia sclerotiorum,
Valsa mali and
Colletotrichum orbiculare at 50 μg/mL. Notably, compound
3a showed favorable activity against
R. solani (EC
50 = 1.84 μg/mL),
3j exhibited satisfied activity against
B. cinerea (EC
50 = 2.47 μg/mL), and
3m exerted excellent activity against
S. sclerotiorum (EC
50 = 1.05 μg/mL), which are better than hinokitiol (2.00, 11.3 and 5.40 μg/mL).